Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioScrip, Inc. (NASDAQ: BIOS).

Full DD Report for BIOS

You must become a subscriber to view this report.


Recent News from (NASDAQ: BIOS)

Factors of Influence in 2018, Key Indicators and Opportunity within Aerie Pharmaceuticals, BioScrip, Celsion, Primoris Services, Cyclacel Pharmaceuticals, and Barnes Group - New Research Emphasizes Economic Growth
NEW YORK, Sept. 05, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), BioScrip, Inc. (NASDAQ:BIOS),...
Source: GlobeNewswire
Date: September, 05 2018 07:30
Factors of Influence in 2018, Key Indicators and Opportunity within BioScrip, Powell Industries, Portola Pharmaceuticals, Daktronics, Cable One, and Park-Ohio - New Research Emphasizes Economic Growth
NEW YORK, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BioScrip, Inc. (NASDAQ:BIOS), Powell Industries, Inc. (NASDAQ:POWL), Port...
Source: GlobeNewswire
Date: August, 16 2018 08:25
BioScrip, Inc. (BIOS) CEO Dan Greenleaf on Q2 2018 Results - Earnings Call Transcript
BioScrip, Inc. (BIOS) Q2 2018 Results Earnings Conference Call August 7, 2018, 09:00 AM ET Executives Matt Dexter - VP, Deputy General Counsel. Dan Greenleaf - President and CEO Steve Deitsch - SVP, CFO and Treasurer Analysts Brooks O'Neil - Lake Street Capital Markets Br...
Source: SeekingAlpha
Date: August, 07 2018 12:48
BioScrip misses by $0.02, beats on revenue
BioScrip (NASDAQ: BIOS ): Q2 EPS of -$0.14 misses by $0.02 . More news on: BioScrip, Inc., Earnings news and commentary, Stocks on the move, Consumer stocks news, Read more ...
Source: SeekingAlpha
Date: August, 07 2018 08:02
BioScrip Reports Second Quarter 2018 Financial Results
DENVER, Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2018 financial results. Second Quarter 2018 Highlights ...
Source: GlobeNewswire
Date: August, 07 2018 08:00
BioScrip Appoints Leslie McIntosh as Chief Human Resources Officer
DENVER, July 30, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the appointment of Leslie McIntosh as Senior Vice President, Chief Human Resources ...
Source: GlobeNewswire
Date: July, 30 2018 08:30
BioScrip to Present at the 38th Annual Canaccord Genuity Growth Conference
DENVER, July 23, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, and Stephen M. Dei...
Source: GlobeNewswire
Date: July, 23 2018 16:30
Initiating Free Research Reports on Horizon Pharma and Three Other Healthcare Equities
Stock Research Monitor: IRWD, SUPN, and BIOS LONDON, UK / ACCESSWIRE / July 19, 2018 / If you want a free Stock Review on HZNP sign up now at www.wallstequities.com/registration . On Wednesday, benchmark US indices were mixed as the NASDAQ Composite closed the trading session down 0.01...
Source: ACCESSWIRE IA
Date: July, 19 2018 07:50
BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference Call
DENVER, July 18, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the second quar...
Source: GlobeNewswire
Date: July, 18 2018 16:30
BioScrip Appoints Richard Denness as Chief Commercial Officer
DENVER, July 10, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the appointment of Richard Denness as Senior Vice President, Chief Commercial Offic...
Source: GlobeNewswire
Date: July, 10 2018 08:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-143.843.834.053.81846,808
2018-12-134.103.964.143.92604,643
2018-12-124.034.014.133.891,657,449
2018-12-113.763.843.863.731,379,690
2018-12-103.763.743.883.7251,076,742

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1467,782221,61630.5853Cover
2018-12-1354,258132,83840.8452Short
2018-12-12135,708620,60021.8672Cover
2018-12-1142,095328,74012.8050Cover
2018-12-1095,662248,58138.4832Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BIOS.


About BioScrip, Inc. (NASDAQ: BIOS)

Logo for BioScrip, Inc. (NASDAQ: BIOS)

Not available

 

Contact Information

 

 

Current Management

  • Richard H. Friedman / CEO

Current Share Structure

  • Market Cap: $310,304,483 - 05/14/2018
  • Issue and Outstanding: 127,697,318 - 03/21/2018

 


Recent Filings from (NASDAQ: BIOS)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 04 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 26 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: March, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: February, 26 2018

 

 


Daily Technical Chart for (NASDAQ: BIOS)

Daily Technical Chart for (NASDAQ: BIOS)


Stay tuned for daily updates and more on (NASDAQ: BIOS)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BIOS)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIOS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BIOS and does not buy, sell, or trade any shares of BIOS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/